equityflowunderstand the flow and follow it

EquityFlow › Companies › Nintx

Nintx

biotech · BR

Next Innovative Therapeutics: Brazilian biotech developing drugs from national biodiversity for multifactorial diseases

Funding history

Date	Round	Amount
Dec 2024	Funding round Brazilian biotech Nintx raised US$10M from investors including Fundo Pitanga, ECOA Capital, MOV Investimentos, Tiaraju and Adeste to accelerate its biodiversity-based drug research.	$10M

Investors

Tap an investor to see what else they have backed.

Adeste Ecoa Capital Fundo Pitanga MOV Investimentos Tiaraju

Other companies in biotech

Antag Therapeutics Adcendo Freya Biosciences TXN Systems Promise Bio Concinnity Genetics Noema Pharma MabGenesis RadioNano Therapeutics Citryll Alveron Pharma AQEMIA

Other companies in BR

Helena Asaas ADD IT Skyone Uncover Vitrify Pax SolarZ Segura Draiven Rabt Automation Aimirim

Other companies at Unknown stage

&Charge /dev/agents 123-Transporter 123fahrschule 13Hz 1Global 1Komma5°1MT Nation 1Password 20Face 21.co 2NA FISH

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.